These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2094719)

  • 1. High-performance liquid chromatographic analysis of chlorambucil tert.-butyl ester and its active metabolites chlorambucil and phenylacetic mustard in plasma and tissue.
    Greig NH; Stahle PL; Shetty HU; Genka S; John V; Soncrant TT; Rapoport SI
    J Chromatogr; 1990 Dec; 534():279-86. PubMed ID: 2094719
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
    Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
    Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain.
    Greig NH; Daly EM; Sweeney DJ; Rapoport SI
    Cancer Chemother Pharmacol; 1990; 25(5):320-5. PubMed ID: 2306791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.
    Genka S; Deutsch J; Shetty UH; Stahle PL; John V; Lieberburg IM; Ali-Osman F; Rapoport SI; Greig NH
    Clin Exp Metastasis; 1993 Mar; 11(2):131-40. PubMed ID: 8444006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of deuterated analogues of chlorambucil by the rat.
    Farmer PB; Foster AB; Jarman M; Newell DR; Oddy MR; Kiburis JH
    Chem Biol Interact; 1979 Dec; 28(2-3):211-24. PubMed ID: 549741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatographic assay for chlorambucil and phenylacetic mustard in plasma.
    Lohmar F; Musch E; Von Unruh GE; Mühlenbruch BJ
    J Chromatogr; 1989 Oct; 495():281-7. PubMed ID: 2613814
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.
    Lee FY; Coe P; Workman P
    Cancer Chemother Pharmacol; 1986; 17(1):21-9. PubMed ID: 3698173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.
    Musch E; Malek M; Peter-Katalinic J; Egge H; Rink H; Lathan B; Riedel E
    Cancer Chemother Pharmacol; 1992; 29(4):297-304. PubMed ID: 1537076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography of chlorambucil analogues.
    Workman P; Oppitz M; Donaldson J; Lee FY
    J Chromatogr; 1987 Nov; 422():315-21. PubMed ID: 3437020
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard.
    Ehrsson H; Wallin I; Simonsson B; Hartvig P; Oberg G
    Eur J Clin Pharmacol; 1984; 27(1):111-4. PubMed ID: 6489421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.
    Greig NH; Sweeney DJ; Rapoport SI
    Cancer Chemother Pharmacol; 1988; 21(1):1-8. PubMed ID: 3342460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatography.
    Newell DR; Hart LI; Harrap KR
    J Chromatogr; 1979 Sep; 164(1):114-9. PubMed ID: 541393
    [No Abstract]   [Full Text] [Related]  

  • 13. Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.
    Hartvig P; Simonsson B; Oberg G; Wallin I; Ehrsson H
    Eur J Clin Pharmacol; 1988; 35(5):551-4. PubMed ID: 3069479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of prednimustine and chlorambucil in the rat.
    Newell DR; Shepherd CR; Harrap KR
    Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration.
    Greig NH; Genka S; Daly EM; Sweeney DJ; Rapoport SI
    Cancer Chemother Pharmacol; 1990; 25(5):311-9. PubMed ID: 2306790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of chlorambucil in vitro: effects of fluid matrix, human gastric juice, plasma proteins and red cells.
    Löf K; Hovinen J; Reinikainen P; Vilpo LM; Seppälä E; Vilpo JA
    Chem Biol Interact; 1997 Mar; 103(3):187-98. PubMed ID: 9134009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid assay for plasma chlorambucil and phenyl acetic mustard using reversed-phase liquid chromatography.
    Zakaria M; Brown PR
    J Chromatogr; 1982 Jul; 230(2):381-9. PubMed ID: 7107783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol ester formation by transesterification of chlorambucil: a novel pathway in drug metabolism.
    Gunnarsson PO; Johansson SA; Svensson L
    Xenobiotica; 1984 Jul; 14(7):569-74. PubMed ID: 6506771
    [No Abstract]   [Full Text] [Related]  

  • 19. High-performance liquid chromatography of chlorambucil prodrugs structurally related to lipids in rat plasma.
    Gonçalves JC; Razzouk C; Poupaert JH; Dumont P
    J Chromatogr; 1989 Sep; 494():389-96. PubMed ID: 2584338
    [No Abstract]   [Full Text] [Related]  

  • 20. Mass spectrometry of chlorambucil, its degradation products, and its metabolite in biological samples.
    Chang SY; Larcom BJ; Alberts DS; Larsen B; Walson PD; Sipes IG
    J Pharm Sci; 1980 Jan; 69(1):80-4. PubMed ID: 7354450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.